U.S. Capital Markets Stock News

NYSE:FICO
NYSE:FICOSoftware

Is It Time To Revisit Fair Isaac (FICO) After Its Steep One Year Share Price Slide?

Wondering whether Fair Isaac at around US$1,035.50 a share still makes sense for your portfolio, or if the recent price leaves limited room for value? This article breaks down what the numbers are saying. The stock is up 3.1% over the last week, although it shows a 2.5% decline over 30 days and a much steeper 37.0% decline year to date and 49.4% decline over the past year, set against gains of 41.5% over 3 years and 108.7% over 5 years. Recent attention on Fair Isaac has focused on how...
NYSE:CMS
NYSE:CMSIntegrated Utilities

A Look At CMS Energy (CMS) Valuation After Reaffirmed 2026 Guidance And Higher First Quarter Earnings

CMS Energy (CMS) has just reported first quarter 2026 earnings, reaffirming its adjusted earnings guidance for the year and underscoring improved operating results supported by constructive regulatory decisions in Michigan. See our latest analysis for CMS Energy. The share price has eased in recent weeks, with a 1 month share price return of 2.4% decline and a 7 day share price return of 0.3% decline. However, a 90 day share price return of 6.4% and 1 year total shareholder return of 7.4%...
NYSE:ESI
NYSE:ESIChemicals

Element Solutions (ESI) Is Up 6.6% After AI-Fueled Guidance Hike Despite Lower EPS - Has The Bull Case Changed?

In late April 2026, Element Solutions Inc reported first-quarter 2026 results showing sales rising to US$840 million from US$593.7 million a year earlier, while net income fell to US$55.9 million from US$98 million and diluted EPS from continuing operations decreased to US$0.23 from US$0.40. The quarter was marked by double-digit organic growth in the Electronics segment, strong contributions from the newly acquired Micromax and EFC businesses, and a higher full-year adjusted EBITDA guidance...
NYSE:RHP
NYSE:RHPHotel and Resort REITs

Ryman Hospitality Properties (RHP) Q1 2026 Earnings Highlight Dividend And Interest Coverage Concerns

Ryman Hospitality Properties (RHP) started 2026 with Q1 revenue of $664.6 million and basic EPS of $1.12, alongside trailing twelve month revenue of $2.6 billion and EPS of $4.01 that frame the latest quarter in a broader context. Over the past year, revenue has moved from $2.3 billion in the 2024 Q4 trailing period to $2.6 billion in the latest trailing snapshot, while basic EPS has tracked between $4.54 and $4.01 over those same intervals. This gives investors a clearer view of the earnings...
NasdaqGS:PENN
NasdaqGS:PENNHospitality

Is It Time To Reconsider PENN Entertainment (PENN) After Long Term Share Price Weakness?

If you are wondering whether PENN Entertainment's current share price still reflects good value, the recent performance and valuation checks give you a useful starting point. The stock last closed at US$17.27, with returns of 0.2% over 7 days, 15.1% over 30 days, 16.3% year to date, 8.1% over 1 year, and longer term declines of 34.7% over 3 years and 80.1% over 5 years that many investors will be weighing up. Recent coverage has focused on PENN Entertainment's position in the wider U.S...
NYSE:P
NYSE:PTech

A Look At Everpure (P) Valuation After Earnings Beat And Mixed Analyst Views

Everpure earnings spark fresh interest Everpure (P) has drawn renewed attention after its fourth quarter fiscal 2026 earnings topped Wall Street expectations, a result that has sharpened the debate around growth potential and margin pressures. See our latest analysis for Everpure. The share price reaction has been steady rather than abrupt, with a 17.3% 1 month share price return around the earnings release. The 1 year total shareholder return of 49.7% and 5 year total shareholder return of...
NasdaqGS:VSEC
NasdaqGS:VSECAerospace & Defense

Should VSE’s New Blank Check Preferred Authorization Reshape the Capital Playbook for VSEC Investors?

In late April 2026, VSE Corporation sought stockholder approval to amend its Restated Certificate of Incorporation to authorize 10,000,000 shares of blank check preferred stock, aiming to enhance capital flexibility for M&A, capital structure optimization, and tailored investor financing ahead of a May 7, 2026 meeting. The proposal’s built-in safeguards, such as no preset superior voting rights, no current issuance plans, and required majority approval of all outstanding shares, highlight...
NasdaqGS:SPSC
NasdaqGS:SPSCSoftware

SPS Commerce (SPSC) Q1 EPS Pullback Tests Bullish Earnings Growth Narrative

Q1 2026 earnings snapshot for SPS Commerce (SPSC) SPS Commerce (SPSC) has opened 2026 with Q1 revenue of US$192.1 million, basic EPS of US$0.53 and net income of US$19.7 million, providing new information for shareholders watching the US$58.92 share price. Over recent periods, the company has reported revenue of US$170.9 million in Q4 2024 and US$192.1 million in Q1 2026, while trailing twelve month EPS is US$2.41 on net income of US$90.9 million. With earnings and margins already central to...
NYSE:WTRG
NYSE:WTRGWater Utilities

Assessing Essential Utilities (WTRG) Valuation After Recent Share Price Weakness

What recent price moves say about Essential Utilities Essential Utilities (WTRG) has seen its share price soften recently, with a 0.4% decline in the past day, 3.8% over the past week, and a 6.4% drop over the past month. See our latest analysis for Essential Utilities. That recent 6.4% 30 day share price return, alongside a 1.6% share price decline year to date and a 3.3% fall in the 1 year total shareholder return, suggests momentum has been fading both in the short term and over a longer...
NYSE:AEM
NYSE:AEMMetals and Mining

Agnico Eagle Mines (AEM) Net Margin At 39.5% Challenges Softer Earnings Forecast Narratives

Agnico Eagle Mines (NYSE:AEM) opened 2026 with Q1 revenue of US$4.1b and basic EPS of US$3.39, against a trailing twelve month revenue base of US$13.5b and EPS of US$10.66 that reflects strong earnings growth of 126.1% over the past year. Over recent quarters, revenue has moved from US$2.2b in Q4 2024 to US$2.5b, US$2.8b, US$3.1b and US$3.6b in 2025, before reaching US$4.1b in Q1 2026. Basic EPS has stepped from US$1.02 to US$1.62, US$2.13, US$2.10, US$3.04 and now US$3.39, with trailing net...
NYSE:BIO
NYSE:BIOLife Sciences

Bio Rad Laboratories (BIO) EPS Loss Revives Concerns Over Volatile Profit Narratives

Bio-Rad Laboratories (BIO) opened 2026 with Q1 revenue of US$592.1 million and a basic EPS loss of US$19.55, in a quarter where trailing twelve month EPS stood at US$6.24 on revenue of US$2.59 billion. The company has seen quarterly revenue move from US$585.4 million and EPS of US$2.29 in Q1 2025 to US$592.1 million and EPS of US$19.55 loss in Q1 2026. Over the same period, trailing twelve month net income shifted from a loss of US$2.16 billion in Q1 2025 to a profit of US$168.8 million in Q1...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Atlassian (TEAM) Q3 Loss Deepens To US$98m And Tests Bullish Profitability Narrative

Atlassian (TEAM) just posted Q3 2026 results with revenue of US$1.8 billion, a basic EPS loss of US$0.38 and net income loss of US$98.4 million, setting the tone for another quarter where growth and profitability remain in tension. The company has seen quarterly revenue move from US$1.36 billion in Q3 2025 to US$1.79 billion in Q3 2026. Over that span, basic EPS ranged from a loss of US$0.27 in Q3 2025 to a loss of US$0.38 in the latest quarter, leaving investors focused squarely on how...
NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

A Look At Corvus Pharmaceuticals (CRVS) Valuation After Adding Immunology Leader Dr. Andrew C. Chan To Its Board

Corvus Pharmaceuticals (CRVS) has drawn investor attention after appointing immunologist and drug development leader Dr. Andrew C. Chan to its Board of Directors. The move highlights the company’s focus on research driven decision making. See our latest analysis for Corvus Pharmaceuticals. The latest share price of US$15.46 comes after a mixed few months, with a 7.1% 30 day share price return set against a 25.3% decline over 90 days. At the same time, a year to date share price return of...
NasdaqGS:ADTN
NasdaqGS:ADTNCommunications

ADTRAN (ADTN) Deepens GLDS Ties and Gains FCC Clarity: How Durable Is Its Broadband Edge?

In April 2026, ADTRAN Holdings announced an expanded phase of its partnership with GLDS to deliver billing-driven, zero-touch automation across subscriber, service and device lifecycles, while also securing conditional FCC approval that exempts its SDG carrier-grade router portfolio from Covered List restrictions through October 1, 2027. Together, these developments strengthen ADTRAN’s role in automated broadband service management and provide greater regulatory clarity for service providers...
NYSE:GPI
NYSE:GPISpecialty Retail

Is It Time To Revisit Group 1 Automotive (GPI) After Recent Share Price Weakness?

If you are wondering whether Group 1 Automotive at around US$353.67 is a bargain or fully priced, the key is to understand what the current share price implies about the company’s value. The stock has moved 3.6% over the last week and 6.9% over the last month. Year to date it shows a 9.9% decline and a 13.8% decline over the past year, set against longer term returns of 63.3% over three years and 115.7% over five years. Recent coverage of Group 1 Automotive has focused on the company’s...
NYSE:PEN
NYSE:PENMedical Equipment

Is Penumbra (PEN) Pricing In Too Much Growth After Recent Trial Developments

Wondering if Penumbra at around US$325.33 is offering you real value or just a rich price tag? This article walks through what the latest numbers actually say about the stock. The share price shows a 1.4% decline over the last 7 days and a 1.1% decline over the last 30 days, while returns stand at 5.1% year to date and 9.9% over the past year. Recent coverage around Penumbra has focused on its position in the medical equipment space and how investors are weighing growth potential against...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

Is Nurix’s Pan-Mutant BRAF Degrader Data Reshaping The Investment Case For Nurix Therapeutics (NRIX)?

At the April 2026 AACR Annual Meeting, Nurix Therapeutics reported new preclinical and early clinical data showing progress across its targeted protein degradation oncology pipeline, including programs aimed at pan-mutant BRAF, CBL-B, and Aurora kinase A. Beyond individual drug candidates, the presentations underscored how Nurix’s induced proximity and protein degradation platforms may overcome resistance and pathway limitations that challenge traditional cancer therapies. With this context...
NYSE:APAM
NYSE:APAMCapital Markets

Artisan Partners Weighs Acquisitions And New Credit Strategies With Excess Capital

Artisan Partners Asset Management (NYSE:APAM) is signaling a push into acquisitions and new investment strategies in differentiated credit, private equity and real assets. Management has highlighted an active M&A pipeline, interest in both individual hires and larger deals, and continued R&D efforts to expand the firm’s platform. The company plans to pursue these opportunities while keeping significant excess capital available for potential transactions and organic growth...
NasdaqGS:ENSG
NasdaqGS:ENSGHealthcare

Ensign Group Q1 EPS Strength Reinforces Bullish Earnings Narrative Despite Premium P/E

Ensign Group (ENSG) just posted Q1 2026 results with revenue of US$1.4 billion, basic EPS of US$1.73 and net income of US$99.7 million, setting the tone for the new fiscal year. Over the past five quarters, revenue has moved from US$1.17 billion in Q1 2025 to US$1.39 billion in Q1 2026, while quarterly basic EPS has increased from US$1.41 to US$1.73, with trailing twelve month net income at US$363.4 million. With net profit margins over the last year near 7%, the focus now is on how...
NYSE:PFS
NYSE:PFSBanks

Is It Too Late To Consider Provident Financial Services (PFS) After Strong Regional Bank Rebound?

For readers wondering whether Provident Financial Services at around US$22.38 is still offering value or if most of the opportunity is already priced in, this article walks through what the current numbers suggest. The stock has recent returns of 0.1% over 7 days, 5.2% over 30 days, 13.3% year to date, 37.6% over 1 year, 67.1% over 3 years and 13.2% over 5 years. These figures naturally raise questions about how much upside or downside might be left. Recent news flow around Provident...
NYSE:MATX
NYSE:MATXShipping

How Investors Are Reacting To Matson (MATX) Expanding Its Buyback And Maintaining Its Dividend

In April 2026, Matson, Inc.’s Board declared a past second-quarter dividend of US$0.36 per share, payable on June 4, 2026 to shareholders of record on May 7, 2026. On the same day, Matson also expanded and extended its share repurchase authorization to 18,000,000 shares through December 31, 2029, highlighting ongoing cash returns to shareholders. We’ll now examine how Matson’s expanded share repurchase authorization could influence the company’s existing investment narrative and future...
NYSE:ELS
NYSE:ELSResidential REITs

Assessing Equity LifeStyle Properties (ELS) Valuation After A Recent Share Price Pullback

Event context and recent share performance Equity LifeStyle Properties (ELS) has recently drawn investor attention after a mild share pullback, with the stock closing at $62.82 and showing small negative returns over the week, month and past 3 months. See our latest analysis for Equity LifeStyle Properties. That recent pullback sits against a quieter backdrop, with a 5.07% year to date share price return but a 1.05% decline in 1 year total shareholder return hinting that momentum has...
NYSE:ESS
NYSE:ESSResidential REITs

A Look At Essex Property Trust’s Valuation After Recent Share Price Momentum

Essex Property Trust overview after recent performance Essex Property Trust (ESS) has drawn fresh attention after recent price moves, with the stock last closing at US$263.35 and showing mixed total returns across the past year and past 3 months. See our latest analysis for Essex Property Trust. The share price has picked up recently, with a 1 month share price return of 8.34% and a 3 month share price return of 4.56%. However, the 1 year total shareholder return of 6.45% contrasts with a 3...
NYSE:DHI
NYSE:DHIConsumer Durables

D.R. Horton Enters Rochester As Investors Weigh Valuation And Momentum

D.R. Horton (NYSE:DHI) has launched its first new home community in Rochester, Minnesota. The move marks the company’s entry into the Rochester housing market. This expansion adds a new Upper Midwest city to D.R. Horton's existing geographic footprint. D.R. Horton, a large U.S. homebuilder, focuses on building and selling new homes across a range of price points. By entering Rochester, Minnesota, NYSE:DHI is extending its presence into a new metro area in the Upper Midwest, a region that...